Medical stores across Madhya Pradesh remained closed during a statewide protest against online medicine sales. Chemists and pharmacy associations said unregulated digital drug sales are affecting local businesses and raising concerns over patient safety.
The protest impacted several cities, including Bhopal, Indore, Gwalior, Jabalpur, and Ujjain.
Chemists Oppose Online Drug Sales
Pharmacy operators claimed online medicine platforms are selling drugs without proper checks. Protesters said medicines should only be sold after physical prescription verification and pharmacist supervision.
The MP medical stores shut protest was organised by trader and chemist associations demanding tighter control over e-pharmacy operations.
Many medical shops kept shutters down throughout the day as part of the protest.
Concerns Over Patient Safety
Chemists said online drug delivery can increase misuse of medicines and self-medication. They also raised concerns about fake medicines, storage quality, and prescription verification.
Pharmacy owners argued that local chemists follow licensing rules and maintain direct communication with patients and doctors.
The MP medical stores shut action highlighted growing tension between traditional pharmacies and digital healthcare platforms.
Emergency Services Continue
Despite the protest, emergency medicine services remained available in many areas. Some hospital-linked pharmacies and selected stores continued operations for critical patients.
Officials monitored the situation to avoid disruption in emergency healthcare services.
Government Action Demanded
Trader groups urged the government to introduce stronger regulations for online medicine sales. They demanded equal compliance rules for digital and offline pharmacy businesses.
The MP medical stores shut protest may continue if authorities do not address the issue, according to pharmacy association members.
What Happens Next
Chemist associations are expected to hold discussions with government officials in the coming days. Further protest plans may be announced if demands remain unresolved.
The issue reflects a larger national debate over regulation, digital healthcare growth, and consumer safety in India’s medicine market
